Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

Several studies demonstrated the efficacy of the B-cell depletion therapy with rituximab (RTX) in RA patients, including those unresponsive to anti- TNF therapy, underlying the important role of B cells in this disease (1-5). Several recent papers have demonstrated a differential effects of RTX in d...

Full description

Bibliographic Details
Main Authors: F. Fischetti, L.M. Bambara, A. Carletto, M. Cutolo, P. Sarzi-Puttini, R. Pellerito, C. Fabro, E. Pontarini, M.A. Cimmino, P. Morassi, F. Atzeni, M. Saracco, M. Manfredi, M. Benucci, S. Lombardi, L. Quartuccio, M. Fabris, F. Curcio, E. Tonutti, S. De VIta
Format: Article
Language:English
Published: PAGEPress Publications 2011-06-01
Series:Reumatismo
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/490
_version_ 1828365845757165568
author F. Fischetti
L.M. Bambara
A. Carletto
M. Cutolo
P. Sarzi-Puttini
R. Pellerito
C. Fabro
E. Pontarini
M.A. Cimmino
P. Morassi
F. Atzeni
M. Saracco
M. Manfredi
M. Benucci
S. Lombardi
L. Quartuccio
M. Fabris
F. Curcio
E. Tonutti
S. De VIta
author_facet F. Fischetti
L.M. Bambara
A. Carletto
M. Cutolo
P. Sarzi-Puttini
R. Pellerito
C. Fabro
E. Pontarini
M.A. Cimmino
P. Morassi
F. Atzeni
M. Saracco
M. Manfredi
M. Benucci
S. Lombardi
L. Quartuccio
M. Fabris
F. Curcio
E. Tonutti
S. De VIta
author_sort F. Fischetti
collection DOAJ
description Several studies demonstrated the efficacy of the B-cell depletion therapy with rituximab (RTX) in RA patients, including those unresponsive to anti- TNF therapy, underlying the important role of B cells in this disease (1-5). Several recent papers have demonstrated a differential effects of RTX in depleting B-cells and blocking plasma cell generation at the synovial and at the bone marrow level (7-9). This differential effect may explain why among patients who respond to RTX, some relapse while others show a very prolonged response, independently from the reappearance of B-cells in the peripheral blood (6). However, the efficacy of RTX may also depend on the individual genetic predisposition. At this regard, very few data were produced by now.
first_indexed 2024-04-14T05:37:13Z
format Article
id doaj.art-22935c537dcc40a9b1adadb7989db87f
institution Directory Open Access Journal
issn 0048-7449
2240-2683
language English
last_indexed 2024-04-14T05:37:13Z
publishDate 2011-06-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj.art-22935c537dcc40a9b1adadb7989db87f2022-12-22T02:09:35ZengPAGEPress PublicationsReumatismo0048-74492240-26832011-06-0162425325810.4081/reumatismo.2010.253Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritisF. FischettiL.M. BambaraA. CarlettoM. CutoloP. Sarzi-PuttiniR. PelleritoC. FabroE. PontariniM.A. CimminoP. MorassiF. AtzeniM. SaraccoM. ManfrediM. BenucciS. LombardiL. QuartuccioM. FabrisF. CurcioE. TonuttiS. De VItaSeveral studies demonstrated the efficacy of the B-cell depletion therapy with rituximab (RTX) in RA patients, including those unresponsive to anti- TNF therapy, underlying the important role of B cells in this disease (1-5). Several recent papers have demonstrated a differential effects of RTX in depleting B-cells and blocking plasma cell generation at the synovial and at the bone marrow level (7-9). This differential effect may explain why among patients who respond to RTX, some relapse while others show a very prolonged response, independently from the reappearance of B-cells in the peripheral blood (6). However, the efficacy of RTX may also depend on the individual genetic predisposition. At this regard, very few data were produced by now.http://www.reumatismo.org/index.php/reuma/article/view/490
spellingShingle F. Fischetti
L.M. Bambara
A. Carletto
M. Cutolo
P. Sarzi-Puttini
R. Pellerito
C. Fabro
E. Pontarini
M.A. Cimmino
P. Morassi
F. Atzeni
M. Saracco
M. Manfredi
M. Benucci
S. Lombardi
L. Quartuccio
M. Fabris
F. Curcio
E. Tonutti
S. De VIta
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
Reumatismo
title Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
title_full Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
title_fullStr Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
title_full_unstemmed Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
title_short Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
title_sort study on the possible role of the 174g c il 6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
url http://www.reumatismo.org/index.php/reuma/article/view/490
work_keys_str_mv AT ffischetti studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT lmbambara studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT acarletto studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT mcutolo studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT psarziputtini studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT rpellerito studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT cfabro studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT epontarini studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT macimmino studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT pmorassi studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT fatzeni studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT msaracco studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT mmanfredi studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT mbenucci studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT slombardi studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT lquartuccio studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT mfabris studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT fcurcio studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT etonutti studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis
AT sdevita studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis